CureVac’s COVID-19 Vaccine Failed in Preliminary Trial Results

CureVac’s COVID-19 Vaccine Failed in Preliminary Trial Results

A coronavirus vaccine manufactured by German company CureVac was only 47 per cent effective in interim results, the company announced Wednesday, a major setback that was due largely to the difficulties posed by new variants. The company’s 40,000 person trial was conducted in 10 countries in Latin America and Europe, where “at least” 13 different […]

Read More